Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

January 31, 2007

Study Completion Date

March 31, 2009

Conditions
Breast Cancer
Interventions
BIOLOGICAL

trastuzumab

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

paclitaxel

DRUG

tamoxifen citrate

Trial Locations (45)

10010

Veterans Affairs Medical Center - New York, New York

10016

Kaplan Cancer Center, New York

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

12208

Veterans Affairs Medical Center - Albany, Albany

14642

University of Rochester Cancer Center, Rochester

19096

CCOP - MainLine Health, Wynnewood

19104

University of Pennsylvania Cancer Center, Philadelphia

21231

Johns Hopkins Oncology Center, Baltimore

30033

Veterans Affairs Medical Center - Atlanta (Decatur), Decatur

30322

Emory University Hospital - Atlanta, Atlanta

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

46202

Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis

48106

CCOP - Ann Arbor Regional, Ann Arbor

53226

Medical College of Wisconsin, Milwaukee

53295

Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee

53705

Veterans Affairs Medical Center - Madison, Madison

53792

University of Wisconsin Comprehensive Cancer Center, Madison

55416

CCOP - Metro-Minnesota, Saint Louis Park

55905

Mayo Clinic Cancer Center, Rochester

58122

CCOP - Merit Care Hospital, Fargo

60201

CCOP - Evanston, Evanston

60611

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

Veterans Affairs Medical Center - Chicago (Lakeside), Chicago

61602

CCOP - Illinois Oncology Research Association, Peoria

61801

CCOP - Carle Cancer Center, Urbana

62526

CCOP - Central Illinois, Decatur

68131

CCOP - Missouri Valley Cancer Consortium, Omaha

70121

CCOP - Ochsner, New Orleans

74136

CCOP - Sooner State, Tulsa

94304

Veterans Affairs Medical Center - Palo Alto, Palo Alto

94305-5408

Stanford University Medical Center, Stanford

80209-5031

CCOP - Colorado Cancer Research Program, Inc., Denver

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

67214-3882

CCOP - Wichita, Wichita

02111

New England Medical Center Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

49007-3731

CCOP - Kalamazoo, Kalamazoo

07201

Trinitas Hospital - Jersey Street Campus, Elizabeth

08822

Hunterdon Regional Cancer Program, Flemington

07601

CCOP - Northern New Jersey, Hackensack

Hackensack University Medical Center, Hackensack

07962-1956

Morristown Memorial Hospital, Morristown

44106-5065

Ireland Cancer Center, Cleveland

37232-6838

Vanderbilt Cancer Center, Nashville

0001

Pretoria Academic Hospital, Pretoria

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00003992 - Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2 | Biotech Hunter | Biotech Hunter